SE460792B - Metod foer framstaellning av tvaerbunden hyaluronsyragel, tvaerbunden gel framstaelld enligt denna metod, blandning av tvaerbunden hyaluronsyra gel med annan hydrofil polymer samt kompositioner som innehaaller denna gel - Google Patents

Metod foer framstaellning av tvaerbunden hyaluronsyragel, tvaerbunden gel framstaelld enligt denna metod, blandning av tvaerbunden hyaluronsyra gel med annan hydrofil polymer samt kompositioner som innehaaller denna gel

Info

Publication number: SE460792B
Authority: SE; Sweden
Prior art keywords: weight; sodium hyaluronate; gel; hyaluronic acid; hydrophilic polymer
Prior art date: 1984-12-06

Application number

SE8503486A

Other languages

English (en)

Swedish (sv)

Other versions

SE8503486D0 (sv

SE8503486L (sv

Inventor

E A Balazs

A Leshchiner

Original Assignee

Biomatrix Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-12-06

Filing date

1985-07-15

Publication date

1989-11-20

1985-07-15 Application filed by Biomatrix Inc filed Critical Biomatrix Inc

1985-07-15 Publication of SE8503486D0 publication Critical patent/SE8503486D0/xx

1986-06-07 Publication of SE8503486L publication Critical patent/SE8503486L/xx

1989-11-20 Publication of SE460792B publication Critical patent/SE460792B/sv

Links

239000000203 mixture Substances 0.000 title claims description 38
238000000034 method Methods 0.000 title claims description 36
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title claims description 25
229920002674 hyaluronan Polymers 0.000 title claims description 25
229960003160 hyaluronic acid Drugs 0.000 title claims description 25
229920001477 hydrophilic polymer Polymers 0.000 title claims description 21
238000002156 mixing Methods 0.000 title description 3
239000000499 gel Substances 0.000 claims description 143
239000000243 solution Substances 0.000 claims description 59
239000000126 substance Substances 0.000 claims description 50
229920000642 polymer Polymers 0.000 claims description 49
229920002385 Sodium hyaluronate Polymers 0.000 claims description 38
229940010747 sodium hyaluronate Drugs 0.000 claims description 38
YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 38
238000006243 chemical reaction Methods 0.000 claims description 28
239000011541 reaction mixture Substances 0.000 claims description 21
238000004132 cross linking Methods 0.000 claims description 20
239000007864 aqueous solution Substances 0.000 claims description 11
102000008186 Collagen Human genes 0.000 claims description 9
108010035532 Collagen Proteins 0.000 claims description 9
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 9
229920001436 collagen Polymers 0.000 claims description 9
229920000669 heparin Polymers 0.000 claims description 9
229960002897 heparin Drugs 0.000 claims description 9
229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 8
239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 8
239000003814 drug Substances 0.000 claims description 8
235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 8
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 7
229940079593 drug Drugs 0.000 claims description 7
-1 polyethylene Polymers 0.000 claims description 7
239000005995 Aluminium silicate Substances 0.000 claims description 6
229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 6
235000012211 aluminium silicate Nutrition 0.000 claims description 6
239000001768 carboxy methyl cellulose Substances 0.000 claims description 6
239000008112 carboxymethyl-cellulose Substances 0.000 claims description 6
229940105329 carboxymethylcellulose Drugs 0.000 claims description 6
235000019197 fats Nutrition 0.000 claims description 6
NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical group O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 6
235000019271 petrolatum Nutrition 0.000 claims description 6
235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 5
150000004676 glycans Chemical class 0.000 claims description 5
229930195733 hydrocarbon Natural products 0.000 claims description 5
150000002430 hydrocarbons Chemical class 0.000 claims description 5
239000003921 oil Substances 0.000 claims description 5
235000019198 oils Nutrition 0.000 claims description 5
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 5
239000010452 phosphate Substances 0.000 claims description 5
239000000049 pigment Substances 0.000 claims description 5
229920001282 polysaccharide Polymers 0.000 claims description 5
239000005017 polysaccharide Substances 0.000 claims description 5
239000000230 xanthan gum Substances 0.000 claims description 5
229920001285 xanthan gum Polymers 0.000 claims description 5
235000010493 xanthan gum Nutrition 0.000 claims description 5
229940082509 xanthan gum Drugs 0.000 claims description 5
239000002253 acid Substances 0.000 claims description 4
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 3
102000009027 Albumins Human genes 0.000 claims description 3
108010088751 Albumins Proteins 0.000 claims description 3
229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
102000016942 Elastin Human genes 0.000 claims description 3
108010014258 Elastin Proteins 0.000 claims description 3
102000006395 Globulins Human genes 0.000 claims description 3
108010044091 Globulins Proteins 0.000 claims description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
102000011782 Keratins Human genes 0.000 claims description 3
108010076876 Keratins Proteins 0.000 claims description 3
239000004166 Lanolin Substances 0.000 claims description 3
239000004698 Polyethylene Substances 0.000 claims description 3
235000013871 bee wax Nutrition 0.000 claims description 3
239000012166 beeswax Substances 0.000 claims description 3
DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical group OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 claims description 3
239000004106 carminic acid Substances 0.000 claims description 3
229940114118 carminic acid Drugs 0.000 claims description 3
235000012730 carminic acid Nutrition 0.000 claims description 3
229940059329 chondroitin sulfate Drugs 0.000 claims description 3
235000019864 coconut oil Nutrition 0.000 claims description 3
239000003240 coconut oil Substances 0.000 claims description 3
229920002549 elastin Polymers 0.000 claims description 3
235000019388 lanolin Nutrition 0.000 claims description 3
229940039717 lanolin Drugs 0.000 claims description 3
229920000573 polyethylene Polymers 0.000 claims description 3
229920001343 polytetrafluoroethylene Polymers 0.000 claims description 3
239000004810 polytetrafluoroethylene Substances 0.000 claims description 3
229910052708 sodium Inorganic materials 0.000 claims description 3
239000011734 sodium Substances 0.000 claims description 3
239000004264 Petrolatum Substances 0.000 claims description 2
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 2
NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims description 2
229940066842 petrolatum Drugs 0.000 claims description 2
AFOSIXZFDONLBT-UHFFFAOYSA-N divinyl sulfone Chemical compound C=CS(=O)(=O)C=C AFOSIXZFDONLBT-UHFFFAOYSA-N 0.000 claims 15
125000000524 functional group Chemical group 0.000 claims 7
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 4
239000004215 Carbon black (E152) Substances 0.000 claims 4
229910001514 alkali metal chloride Inorganic materials 0.000 claims 4
229910000318 alkali metal phosphate Inorganic materials 0.000 claims 4
229910052936 alkali metal sulfate Inorganic materials 0.000 claims 4
229940071826 hydroxyethyl cellulose Drugs 0.000 claims 2
102000004169 proteins and genes Human genes 0.000 claims 2
108090000623 proteins and genes Proteins 0.000 claims 2
229910021653 sulphate ion Inorganic materials 0.000 claims 2
229920003169 water-soluble polymer Polymers 0.000 claims 2
LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 claims 1
JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 66
230000008961 swelling Effects 0.000 description 47
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
238000002360 preparation method Methods 0.000 description 11
150000003839 salts Chemical class 0.000 description 11
230000000694 effects Effects 0.000 description 10
239000002245 particle Substances 0.000 description 9
239000003513 alkali Substances 0.000 description 7
229940099259 vaseline Drugs 0.000 description 7
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 6
238000003756 stirring Methods 0.000 description 6
229920002678 cellulose Polymers 0.000 description 5
239000001913 cellulose Substances 0.000 description 5
230000007423 decrease Effects 0.000 description 5
239000007863 gel particle Substances 0.000 description 5
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
239000002202 Polyethylene glycol Substances 0.000 description 4
239000002537 cosmetic Substances 0.000 description 4
229920001223 polyethylene glycol Polymers 0.000 description 4
AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 3
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
239000012670 alkaline solution Substances 0.000 description 3
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
239000000945 filler Substances 0.000 description 3
239000003205 fragrance Substances 0.000 description 3
229940097043 glucuronic acid Drugs 0.000 description 3
230000007935 neutral effect Effects 0.000 description 3
ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
229920002125 Sokalan® Polymers 0.000 description 2
210000000941 bile Anatomy 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
125000002091 cationic group Chemical group 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
229920001577 copolymer Polymers 0.000 description 2
239000006071 cream Substances 0.000 description 2
238000000502 dialysis Methods 0.000 description 2
239000000975 dye Substances 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
230000007717 exclusion Effects 0.000 description 2
239000010419 fine particle Substances 0.000 description 2
230000007062 hydrolysis Effects 0.000 description 2
238000006460 hydrolysis reaction Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
239000007788 liquid Substances 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
239000000463 material Substances 0.000 description 2
239000011159 matrix material Substances 0.000 description 2
239000002609 medium Substances 0.000 description 2
239000011259 mixed solution Substances 0.000 description 2
230000003020 moisturizing effect Effects 0.000 description 2
239000002091 nanocage Substances 0.000 description 2
229940055577 oleyl alcohol Drugs 0.000 description 2
XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
239000003208 petroleum Substances 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
230000002335 preservative effect Effects 0.000 description 2
150000003457 sulfones Chemical class 0.000 description 2
210000003954 umbilical cord Anatomy 0.000 description 2
WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
KGULFLCOPRYBEV-KTKRTIGZSA-N 2-[2-[2-[(z)-octadec-9-enoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCOCCOCCO KGULFLCOPRYBEV-KTKRTIGZSA-N 0.000 description 1
UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
XXBAQTDVRLRXEV-UHFFFAOYSA-N 3-tetradecoxypropan-1-ol Chemical compound CCCCCCCCCCCCCCOCCCO XXBAQTDVRLRXEV-UHFFFAOYSA-N 0.000 description 1
241000881711 Acipenser sturio Species 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
241000252073 Anguilliformes Species 0.000 description 1
102000009123 Fibrin Human genes 0.000 description 1
108010073385 Fibrin Proteins 0.000 description 1
BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 1
240000006240 Linum usitatissimum Species 0.000 description 1
235000004431 Linum usitatissimum Nutrition 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
SNIXRMIHFOIVBB-UHFFFAOYSA-N N-Hydroxyl-tryptamine Chemical compound C1=CC=C2C(CCNO)=CNC2=C1 SNIXRMIHFOIVBB-UHFFFAOYSA-N 0.000 description 1
CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
235000000208 Solanum incanum Nutrition 0.000 description 1
244000302301 Solanum incanum Species 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
230000002730 additional effect Effects 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
150000001340 alkali metals Chemical class 0.000 description 1
230000002965 anti-thrombogenic effect Effects 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
238000005452 bending Methods 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
238000007385 chemical modification Methods 0.000 description 1
230000001055 chewing effect Effects 0.000 description 1
150000003841 chloride salts Chemical class 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
239000000701 coagulant Substances 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
239000000512 collagen gel Substances 0.000 description 1
210000001520 comb Anatomy 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000006866 deterioration Effects 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
230000000440 effect on coagulation Effects 0.000 description 1
230000001804 emulsifying effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
229950003499 fibrin Drugs 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000011521 glass Substances 0.000 description 1
150000002337 glycosamines Chemical class 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
239000008269 hand cream Substances 0.000 description 1
229940014041 hyaluronate Drugs 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
230000003902 lesion Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
229940100485 methyl gluceth-10 Drugs 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
229960002900 methylcellulose Drugs 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
229940078555 myristyl propionate Drugs 0.000 description 1
229910052754 neon Inorganic materials 0.000 description 1
GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
229940075643 oleth-3 Drugs 0.000 description 1
229940093446 oleth-5 Drugs 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
229920002959 polymer blend Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229940116987 ppg-3 myristyl ether Drugs 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000008569 process Effects 0.000 description 1
230000035484 reaction time Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000011343 solid material Substances 0.000 description 1
PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
108091005994 sulfated proteins Proteins 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000000725 suspension Substances 0.000 description 1
YRZGMTHQPGNLEK-UHFFFAOYSA-N tetradecyl propionate Chemical compound CCCCCCCCCCCCCCOC(=O)CC YRZGMTHQPGNLEK-UHFFFAOYSA-N 0.000 description 1
125000003396 thiol group Chemical group [H]S* 0.000 description 1
238000005406 washing Methods 0.000 description 1
238000005303 weighing Methods 0.000 description 1
230000004580 weight loss Effects 0.000 description 1
239000003871 white petrolatum Substances 0.000 description 1
239000008096 xylene Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Birds (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Polymers & Plastics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Materials Engineering (AREA)
Biochemistry (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Compositions Of Macromolecular Compounds (AREA)

SE8503486A 1984-12-06 1985-07-15 Metod foer framstaellning av tvaerbunden hyaluronsyragel, tvaerbunden gel framstaelld enligt denna metod, blandning av tvaerbunden hyaluronsyra gel med annan hydrofil polymer samt kompositioner som innehaaller denna gel SE460792B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/678,895 US4582865A (en)	1984-12-06	1984-12-06	Cross-linked gels of hyaluronic acid and products containing such gels

Publications (3)

Publication Number	Publication Date
SE8503486D0 SE8503486D0 (sv)	1985-07-15
SE8503486L SE8503486L (sv)	1986-06-07
SE460792B true SE460792B (sv)	1989-11-20

Family

ID=24724742

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SE8503486A SE460792B (sv)	1984-12-06	1985-07-15	Metod foer framstaellning av tvaerbunden hyaluronsyragel, tvaerbunden gel framstaelld enligt denna metod, blandning av tvaerbunden hyaluronsyra gel med annan hydrofil polymer samt kompositioner som innehaaller denna gel
SE8901672A SE501828C2 (sv)	1984-12-06	1989-05-10	Matris bestående av en tvärbunden gel av hyaluronsyra för avgivning av en i matrisen innesluten substans med biologisk eller farmakologisk verkan

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SE8901672A SE501828C2 (sv)	1984-12-06	1989-05-10	Matris bestående av en tvärbunden gel av hyaluronsyra för avgivning av en i matrisen innesluten substans med biologisk eller farmakologisk verkan

Country Status (9)

Country	Link
US (1)	US4582865A (fr)
JP (2)	JPS61138601A (fr)
AU (2)	AU569157B2 (fr)
CA (1)	CA1230186A (fr)
DE (2)	DE3546811C2 (fr)
FR (1)	FR2574414B1 (fr)
GB (4)	GB2168067B (fr)
IT (1)	IT1187737B (fr)
SE (2)	SE460792B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5633001A (en) *	1993-03-19	1997-05-27	Medinvent	Composition and a method for tissue augmentation
US5827937A (en) *	1995-07-17	1998-10-27	Q Med Ab	Polysaccharide gel composition

Families Citing this family (296)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0611694B2 (ja) *	1985-01-29	1994-02-16	生化学工業株式会社	皮膚化粧料
US4863907A (en) *	1984-06-29	1989-09-05	Seikagaku Kogyo Co., Ltd.	Crosslinked glycosaminoglycans and their use
US5128326A (en) *	1984-12-06	1992-07-07	Biomatrix, Inc.	Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US5099013A (en) *	1985-03-12	1992-03-24	Biomatrix, Inc,	Hylan preparation and method of recovery thereof from animal tissues
US4713448A (en) *	1985-03-12	1987-12-15	Biomatrix, Inc.	Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US5202431A (en) *	1985-07-08	1993-04-13	Fidia, S.P.A.	Partial esters of hyaluronic acid
US4851521A (en) *	1985-07-08	1989-07-25	Fidia, S.P.A.	Esters of hyaluronic acid
EP0224987B1 (fr) *	1985-11-29	1992-04-15	Biomatrix, Inc.	Systèmes à base de l'hyaluronanne, de ses dérivés et de ses sels pour la libération de médicaments et leur procédé de fabrication
IT1198449B (it) *	1986-10-13	1988-12-21	F I D I Farmaceutici Italiani	Esteri di alcoli polivalenti di acido ialuronico
AU610512B2 (en) *	1986-12-11	1991-05-23	Biomatrix Incorporated	Improved hyaluronate-poly (ethylene oxide) mixtures
EP0356435B1 (fr) *	1987-03-19	1995-10-18	Arthropharm Pty. Limited	Composes et compositions anti-inflammatoires
US4795741A (en) *	1987-05-06	1989-01-03	Biomatrix, Inc.	Compositions for therapeutic percutaneous embolization and the use thereof
GB8713662D0 (en) *	1987-06-11	1987-07-15	Skandigen Ab	Hyaluronic acid derivatives
US5527893A (en) *	1987-09-18	1996-06-18	Genzyme Corporation	Water insoluble derivatives of polyanionic polysaccharides
US6174999B1 (en)	1987-09-18	2001-01-16	Genzyme Corporation	Water insoluble derivatives of polyanionic polysaccharides
US5017229A (en) *	1990-06-25	1991-05-21	Genzyme Corporation	Water insoluble derivatives of hyaluronic acid
US6610669B1 (en)	1987-09-18	2003-08-26	Genzyme Corporation	Water insoluble derivatives of polyanionic polysaccharides
US4937270A (en) *	1987-09-18	1990-06-26	Genzyme Corporation	Water insoluble derivatives of hyaluronic acid
AU619760B2 (en) *	1987-12-10	1992-02-06	Genzyme Biosurgery Corporation	Hylan preparation and method of recovery thereof from animal tissues
US4888016A (en) *	1988-02-10	1989-12-19	Langerman David W	"Spare parts" for use in ophthalmic surgical procedures
IT1219587B (it) *	1988-05-13	1990-05-18	Fidia Farmaceutici	Polisaccaridi carbossiilici autoreticolati
US5510418A (en) *	1988-11-21	1996-04-23	Collagen Corporation	Glycosaminoglycan-synthetic polymer conjugates
JPH0662678B2 (ja) *	1988-11-28	1994-08-17	電気化学工業株式会社	ヒアルロン酸固定化蛋白質及びその製造方法
US4973473A (en) *	1989-06-23	1990-11-27	Revlon, Inc.	Skin care preparation
US5356883A (en) *	1989-08-01	1994-10-18	Research Foundation Of State University Of N.Y.	Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
CA1340994C (fr) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Traitement de maladies et d'etats pathologiques
US5153174A (en) *	1989-10-30	1992-10-06	Union Carbide Chemicals & Plastics Inc.	Polymer mixtures useful in skin care
WO1992000745A1 (fr) *	1990-07-03	1992-01-23	Autogenesis Technologies, Inc.	Solution viscoelastique a base de collagene destinee a la visco-chirurgie
US5246698A (en) *	1990-07-09	1993-09-21	Biomatrix, Inc.	Biocompatible viscoelastic gel slurries, their preparation and use
US5143724A (en) *	1990-07-09	1992-09-01	Biomatrix, Inc.	Biocompatible viscoelastic gel slurries, their preparation and use
US5824658A (en) *	1990-09-18	1998-10-20	Hyal Pharmaceutical Corporation	Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) *	1990-09-18	1999-11-23	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
US5639738A (en) *	1992-02-20	1997-06-17	Hyal Pharmaceutical Corporation	Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
CA2061703C (fr) *	1992-02-20	2002-07-02	Rudolf E. Falk	Compositions renfermant de l'acide hyaluronique
US5910489A (en) *	1990-09-18	1999-06-08	Hyal Pharmaceutical Corporation	Topical composition containing hyaluronic acid and NSAIDS
US5219360A (en) *	1991-05-10	1993-06-15	Fortis Research Corporation	Mammary prosthesis fill and method of making same
EP0516026A1 (fr) *	1991-05-28	1992-12-02	Takeda Chemical Industries, Ltd.	Hydrogel et méthode pour sa production
US5234914A (en) *	1991-06-11	1993-08-10	Patent Biopharmaceutics, Inc.	Methods of treating hemorrhoids and anorecial disease
WO1994007505A1 (fr) *	1991-07-03	1994-04-14	Norpharmco Inc.	Utilisation de l'acide hyaluronique sous differentes formes contre la recidive de la stenose arterielle
US6103704A (en) *	1991-07-03	2000-08-15	Hyal Pharmaceutical Corporation	Therapeutic methods using hyaluronic acid
US5792753A (en) *	1991-07-03	1998-08-11	Hyal Pharmaceutical Corporation	Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US5990095A (en) *	1991-07-03	1999-11-23	Hyal Pharmaceutical Corporation	Use of hyaluronic acid and forms to prevent arterial restenosis
US6022866A (en) *	1991-07-03	2000-02-08	Hyal Pharmaceutical Corporation	Use of hyaluronic acid and forms to prevent arterial restenosis
US5817644A (en) *	1991-07-03	1998-10-06	Hyal Pharmaceutical Corporation	Targeting of dosages of medicine and therapeutic agents
US5977088A (en) *	1991-07-03	1999-11-02	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
JPH0539480U (ja) *	1991-10-31	1993-05-28	ジユーキ株式会社	ミシンの針棒
EP0544259A1 (fr) *	1991-11-27	1993-06-02	Lignyte Co., Ltd.	Complexe hyaluronique et polyionique biocompatible insoluble dans l'eau et son procédé de préparation
DE4200080A1 (de) *	1992-01-03	1993-09-30	Reinmueller Johannes	Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
CA2072918A1 (fr) *	1992-02-14	1993-08-15	Jian Qin	Polysaccharides modifiees ayant un pouvoir absorbant ameliore et methode de preparation de ces polysaccharides
US6218373B1 (en)	1992-02-20	2001-04-17	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
CA2061567C (fr) *	1992-02-20	1998-02-03	Rudolf E. Falk	Utilisation de l'acide hyaluronique pour reparer les dommages de reperfusion de l'ischemie
US6147059A (en) *	1992-02-20	2000-11-14	Hyal Pharmaceutical Corporation	Formulations containing hyaluronic acid
US5767106A (en) *	1992-02-21	1998-06-16	Hyal Pharmaceutical Corporation	Treatment of disease and conditions associated with macrophage infiltration
US6114314A (en) *	1992-02-21	2000-09-05	Hyal Pharmaceutical Corp.	Formulations containing hyaluronic acid
EP0570230B1 (fr) *	1992-05-15	1998-09-30	Shiseido Company Limited	Préparation externe pour la peau
IT1260154B (it) *	1992-07-03	1996-03-28	Lanfranco Callegaro	Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
US5437867A (en) *	1993-03-19	1995-08-01	Collaborative Laboratories	Solubilizing, thickening and emulsifying cosmetic composition and process for preparation of same
US5531716A (en) *	1993-09-29	1996-07-02	Hercules Incorporated	Medical devices subject to triggered disintegration
US5616568A (en) *	1993-11-30	1997-04-01	The Research Foundation Of State University Of New York	Functionalized derivatives of hyaluronic acid
US5585361A (en)	1994-06-07	1996-12-17	Genzyme Corporation	Methods for the inhibition of platelet adherence and aggregation
US6294202B1 (en)	1994-10-06	2001-09-25	Genzyme Corporation	Compositions containing polyanionic polysaccharides and hydrophobic bioabsorbable polymers
US5690961A (en) *	1994-12-22	1997-11-25	Hercules Incorporated	Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5498705A (en) *	1995-02-22	1996-03-12	Kimberly-Clark Corporation	Modified polysaccharides having improved absorbent properties and process for the preparation thereof
US5612321A (en) *	1995-06-22	1997-03-18	Hercules Incorporated	Antioxidant grafted polysaccharides
US5897880A (en)	1995-09-29	1999-04-27	Lam Pharmaceuticals, Llc.	Topical drug preparations
WO1997017023A1 (fr)	1995-11-07	1997-05-15	Fusion Medical Technologies, Inc.	Procedes et articles utilises pour faire adherer des couches matrices contenant du polysaccharide a des tissus
US6132462A (en) *	1995-12-22	2000-10-17	Santen Pharmaceutical Co., Ltd.	Copolymers formed from three components and intraocular lenses made thereof
SE9601368D0 (sv) *	1996-04-11	1996-04-11	Pharmacia Biotech Ab	Process for the production of a porous cross-linked polysaccharide gel
US6060534A (en)	1996-07-11	2000-05-09	Scimed Life Systems, Inc.	Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US6368356B1 (en)	1996-07-11	2002-04-09	Scimed Life Systems, Inc.	Medical devices comprising hydrogel polymers having improved mechanical properties
CA2273852C (fr)	1996-12-06	2009-09-29	Amgen Inc.	Therapie combinee utilisant un inhibiteur de l'il-1 pour traiter les maladies induites par l'il-1
US6294170B1 (en)	1997-08-08	2001-09-25	Amgen Inc.	Composition and method for treating inflammatory diseases
GB2322864A (en)	1997-03-07	1998-09-09	Polybiomed Ltd	Gel for application to the human or animal body
US6709873B1 (en) *	1997-04-09	2004-03-23	Isodiagnostika Inc.	Method for production of antibodies to specific sites of rapamycin
EP1004597A4 (fr) *	1997-05-28	2002-06-05	Tapic Int Co Ltd	Gel au collagene
US5945457A (en) *	1997-10-01	1999-08-31	A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Science	Process for preparing biologically compatible polymers and their use in medical devices
US5897988A (en) *	1998-01-21	1999-04-27	Yale University	Process and system for selection of mature sperm by surface membrane determinants for assisted reproduction
DE69822285T2 (de) *	1998-02-27	2005-01-27	Stichting Hyppomedics	Verfahren zur Herstellung von vernetzter Hyaluronsäure
US6630457B1 (en)	1998-09-18	2003-10-07	Orthogene Llc	Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
IT1303738B1 (it) *	1998-11-11	2001-02-23	Aquisitio S P A	Processo di reticolazione di polisaccaridi carbossilati.
US7375096B1 (en) *	1998-12-04	2008-05-20	California Institute Of Technology	Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network
JP2002532573A (ja)	1998-12-16	2002-10-02	エスシーエイ・ハイジーン・プロダクツ・ゼイスト・ベー・ブイ	酸性の超吸収性ポリサッカライド
GB9902412D0 (en) *	1999-02-03	1999-03-24	Fermentech Med Ltd	Process
GB9902652D0 (en)	1999-02-05	1999-03-31	Fermentech Med Ltd	Process
EP1174463A4 (fr) *	1999-02-19	2008-04-16	Denki Kagaku Kogyo Kk	Composition gelifiee a base d'acide hyaluronique, procede de production associe et matiere medicale contenant ladite composition
EP1162984A2 (fr)	1999-03-15	2001-12-19	Trustees Of Boston University	UTILISATION D'UN POLYSACCHARIDE NéTICULé POUR INHIBER L'ANGIOGENESE
US20040048021A1 (en) *	1999-03-19	2004-03-11	Wan Barbara Y. F.	Surface modification of substrates
CA2366897C (fr) *	1999-04-06	2009-11-17	Andrew B. Onderdonk	Compositions immunomodulatrices et procedes d'utilisations connexe
US6288043B1 (en) *	1999-06-18	2001-09-11	Orquest, Inc.	Injectable hyaluronate-sulfated polysaccharide conjugates
CA2377544C (fr)	1999-07-28	2008-09-23	United States Surgical Corporation	Barriere anti-adhesion a base d'acide hyaluronique
KR100721752B1 (ko)	2000-01-24	2007-05-25	쿠라레 메디카루 가부시키가이샤	수팽윤성 고분자 겔 및 그 제조법
US6521223B1 (en) *	2000-02-14	2003-02-18	Genzyme Corporation	Single phase gels for the prevention of adhesions
US6749865B2 (en)	2000-02-15	2004-06-15	Genzyme Corporation	Modification of biopolymers for improved drug delivery
KR100375299B1 (ko)	2000-10-10	2003-03-10	주식회사 엘지생명과학	히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법
EP1339349A4 (fr) *	2000-11-14	2007-07-04	R Labs Inc Nv	Gels de laminine et d'acide hyaluronique reticule et leur utilisation dans la culture cellulaire et les implants medicaux
EP1368309B2 (fr) *	2001-02-22	2014-10-01	Anika Therapeutics Inc.	Derives d'hyaluronane thiol-modifies
US20020172712A1 (en) *	2001-03-19	2002-11-21	Alan Drizen	Antiemetic, anti-motion sustained release drug delivery system
US6913765B2 (en)	2001-03-21	2005-07-05	Scimed Life Systems, Inc.	Controlling resorption of bioresorbable medical implant material
US8580290B2 (en) *	2001-05-08	2013-11-12	The Board Of Regents Of The University Of Oklahoma	Heparosan-based biomaterials and coatings and methods of production and use thereof
US20030216758A1 (en) *	2001-12-28	2003-11-20	Angiotech Pharmaceuticals, Inc.	Coated surgical patches
WO2003084571A1 (fr) *	2002-04-08	2003-10-16	Denki Kagaku Kogyo Kabushiki Kaisha	Composition therapeutique destinee aux maladies infectieuses des os
CA2484761C (fr) *	2002-05-24	2010-11-09	Angiotech International Ag	Compositions et procedes d'enrobage d'implants medicaux
DE10223310A1 (de) *	2002-05-24	2003-12-11	Biotronik Mess & Therapieg	Verfahren zum Beschichten von Implantaten mit einer Polysaccharid-Lage
US8313760B2 (en) *	2002-05-24	2012-11-20	Angiotech International Ag	Compositions and methods for coating medical implants
CA2489712C (fr) *	2002-06-21	2016-07-12	University Of Utah Research Foundation	Composes reticules et leurs procedes de preparation et d'utilisation
US7034127B2 (en) *	2002-07-02	2006-04-25	Genzyme Corporation	Hydrophilic biopolymer-drug conjugates, their preparation and use
US7338433B2 (en) *	2002-08-13	2008-03-04	Allergan, Inc.	Remotely adjustable gastric banding method
AU2002327105B2 (en) *	2002-08-16	2007-07-26	Denki Kagaku Kogyo Kabushiki Kaisha	Separate type medical material
BR0306183A (pt) *	2002-08-28	2004-10-19	Inamed Medical Products Corp	Dispositivo de enfaixamento gástrico resistente à fadiga
EP2277551B1 (fr)	2002-09-06	2013-05-08	Cerulean Pharma Inc.	Polymeres a base de cyclodextrine pour l'administration de medicament lies par liaison covalente
DE10252816B4 (de) *	2002-11-13	2008-02-14	Schwan-Stabilo Cosmetics Gmbh & Co. Kg	Kosmetische Zubereitung, sowie ein Verfahren zu ihrer Herstellung und ihre Verwendung
AU2003284634A1 (en) *	2002-11-21	2004-06-15	Chugai Seiyaku Kabushiki Kaisha	Sustained release drug carrier
TWI251596B (en) *	2002-12-31	2006-03-21	Ind Tech Res Inst	Method for producing a double-crosslinked hyaluronate material
LT5098B (lt)	2003-03-28	2004-01-26	Alvyda GUDELEVI�I�T�	Kremų kompozicijos senstančiai odai
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AU2003901834A0 (en) *	2003-04-17	2003-05-01	Clearcoll Pty Ltd	Cross-linked polysaccharide compositions
JP2004323454A (ja) *	2003-04-25	2004-11-18	Chisso Corp	薬剤
WO2005000402A2 (fr) *	2003-05-15	2005-01-06	University Of Utah Research Foundation	Composites anti-adherence et methodes d'utilisation desdits composites
ES2226567B1 (es) *	2003-06-20	2006-07-01	Universidad De Santiago De Compostela	Nanoparticulas de acido hialuronico.
DE10328815A1 (de) *	2003-06-21	2005-01-05	Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin	Beschichtungssystem für Implantate zur Erhöhung der Gewebsverträglichkeit
DE10328816A1 (de)	2003-06-21	2005-01-05	Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin	Implantierbare Stimulationselektrode mit einer Beschichtung zur Erhöhung der Gewebsverträglichkeit
ES2232287B1 (es) *	2003-07-04	2006-11-01	Advanced In Vitro Cell Technologies, S.L.	Nanoparticulas de derivados polioxietilenados.
WO2005012364A2 (fr) *	2003-07-30	2005-02-10	Anteis S.A.	Matrice complexe a usage biomedical
JP4511470B2 (ja) *	2003-10-29	2010-07-28	帝人株式会社	ヒアルロン酸化合物、そのハイドロゲルおよび関節軟骨損傷治療用材料
US20050158356A1 (en) *	2003-11-20	2005-07-21	Angiotech International Ag	Implantable sensors and implantable pumps and anti-scarring agents
WO2005056763A2 (fr) *	2003-12-04	2005-06-23	University Of Utah Research Foundation	Procede et formulation pour l'amelioration de la viabilite de cellules et de tissu stockes
US8524213B2 (en) *	2003-12-30	2013-09-03	Genzyme Corporation	Polymeric materials, their preparation and use
WO2005066215A1 (fr) *	2003-12-30	2005-07-21	Genzyme Corporation	Gels cohesifs de hyaluronane et/ou hylane reticules, preparation et utilisation
MXPA06008256A (es)	2004-01-23	2007-02-20	Allergan Inc	Banda gastrica ajustable de una sola pieza que se asegura de manera liberable.
ATE444045T1 (de) *	2004-03-08	2009-10-15	Allergan Medical S A	Verschlusssystem für röhrenförmige organe
JP2007529280A (ja) *	2004-03-17	2007-10-25	ジェンザイム・コーポレーション	癒着防止スプレー
WO2005094257A2 (fr) *	2004-03-18	2005-10-13	Inamed Medical Products Corporation	Appareil et procede de reglage du volume de ballons intragastriques
WO2006083260A2 (fr)	2004-04-28	2006-08-10	Angiotech Biomaterials Corporation	Compositions et systemes pour la formation de biomateriaux reticules et procedes associes de preparation et d'utilisation
ES2246694B1 (es) *	2004-04-29	2007-05-01	Instituto Cientifico Y Tecnologico De Navarra, S.A.	Nanoparticulas pegiladas.
ES2246695B1 (es) *	2004-04-29	2007-05-01	Instituto Cientifico Y Tecnologico De Navarra, S.A.	Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
US7651702B2 (en) *	2004-05-20	2010-01-26	Mentor Corporation	Crosslinking hyaluronan and chitosanic polymers
WO2005112888A2 (fr) *	2004-05-20	2005-12-01	Mentor Corporation	Procede de preparation d'hydrogels polymeres injectables
ITMI20041373A1 (it)	2004-07-09	2004-10-09	Lima Lto S P A	N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
TW200612991A (en)	2004-09-07	2006-05-01	Chugai Pharmaceutical Co Ltd	Process for producing water-soluble hyaluronic acid modification
JP4875988B2 (ja) *	2004-11-15	2012-02-15	株式会社資生堂	架橋ヒアルロン酸ゲルの製造方法
CN101107270B (zh) *	2004-11-24	2011-11-23	诺维信生物制药丹麦公司	用二乙烯基砜交联透明质酸的方法
EP2664334B1 (fr) *	2004-12-30	2015-03-04	Genzyme Corporation	Schémas posologiques pour viscosupplémentation intra-articulaire
AU2005100176A4 (en) *	2005-03-01	2005-04-07	Gym Tv Pty Ltd	Garbage bin clip
US8251888B2 (en) *	2005-04-13	2012-08-28	Mitchell Steven Roslin	Artificial gastric valve
DE102005030614B4 (de) *	2005-06-30	2014-05-08	Biotissue Ag	Zellfreies Transplantat, dessen Verwendung, Verfahren zu dessen Herstellung, dabei hergestellte Matrix mit Gel und Verfahren zur Herstellung dieser Matrix mit Gel
JP5039552B2 (ja) *	2005-08-04	2012-10-03	帝人株式会社	セルロース誘導体
WO2007026362A2 (fr) *	2005-09-02	2007-03-08	Colbar Lifescience Ltd.	Matrices de polysaccharides et de proteines reticulees et leurs procedes de preparation
CA2623106C (fr)	2005-09-19	2013-12-24	Histogenics Corporation	Matrice support de cellules dont la densite des pores et la porosite sont definies specifiquement de maniere uniforme verticalement et organisees de maniere non aleatoire, et procede de preparation de celle-ci
EP1968614A2 (fr) *	2005-12-14	2008-09-17	Anika Therapeutics Inc.	Traitements de l'arthrite et d'autres troubles musculo-squelettiques avec de l'acide hyaluronique réticulé
EP3028677A1 (fr)	2005-12-14	2016-06-08	Anika Therapeutics Inc.	Traitement de l'arthrite et d'autres troubles musculosquelettiques avec de l'acide hyaluronique réticulé
US8043206B2 (en)	2006-01-04	2011-10-25	Allergan, Inc.	Self-regulating gastric band with pressure data processing
US7798954B2 (en)	2006-01-04	2010-09-21	Allergan, Inc.	Hydraulic gastric band with collapsible reservoir
CA2645227C (fr)	2006-03-07	2015-06-23	Prochon Biotech Ltd.	Derives hydrazido de l'acide hyaluronique
US7674781B2 (en) *	2006-04-28	2010-03-09	Heather Sheardown	Hyaluronic acid-retaining polymers
ITMI20061726A1 (it) *	2006-09-11	2008-03-12	Fidia Farmaceutici	Derivati crosslinkati a base di acido ialuronico reticolato via click chemistry
CN101522164B (zh) *	2006-09-13	2014-03-26	提升肤质产品公司	用于治疗皮肤的化妆品组合物及其方法
JP5030219B2 (ja) *	2007-07-19	2012-09-19	眞知子瀧上	カルボキシメチルセルロースアルカリ塩のゲルの製造方法及びそれによって得られたカルボキシメチルセルロースアルカリ塩のゲル
DE102006047346A1 (de) *	2006-10-06	2008-04-10	Transtissue Technologies Gmbh	Matrix-Gel-Transplantat ohne Zellen
EP2106263B1 (fr) *	2007-01-04	2016-12-21	Hepacore Ltd.	Dérivés réactifs solubles dans l'eau de carboxy polysaccharides et conjugués à base de carboxy polysaccharides et du fibrinogène
US20080176958A1 (en)	2007-01-24	2008-07-24	Insert Therapeutics, Inc.	Cyclodextrin-based polymers for therapeutics delivery
US8529951B1 (en)	2007-02-21	2013-09-10	Anand Ramamurthi	Elastogenic cues and methods for using same
US8987230B2 (en) *	2007-05-01	2015-03-24	National University Corporation Tokyo Medical And Dental University	Hybrid gel comprising chemically crosslinked hyaluronic acid derivative and pharmaceutical composition comprising the same
EP2152743A2 (fr) *	2007-05-23	2010-02-17	Allergan, Inc.	Collagène réticulé et utilisations de ce dernier
US8658148B2 (en)	2007-06-22	2014-02-25	Genzyme Corporation	Chemically modified dendrimers
FR2918377B1 (fr)	2007-07-05	2010-10-08	Estelle Piron	Gel co-reticule de polysaccharides
US20110077737A1 (en) *	2007-07-30	2011-03-31	Allergan, Inc.	Tunably Crosslinked Polysaccharide Compositions
US8318695B2 (en)	2007-07-30	2012-11-27	Allergan, Inc.	Tunably crosslinked polysaccharide compositions
US8697044B2 (en) *	2007-10-09	2014-04-15	Allergan, Inc.	Crossed-linked hyaluronic acid and collagen and uses thereof
EP3498299A1 (fr)	2007-11-16	2019-06-19	Aclaris Therapeutics, Inc.	Compositions et procedes de traitement du purpura
US20090143348A1 (en) *	2007-11-30	2009-06-04	Ahmet Tezel	Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having increased longevity
US8394784B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having multi-stage bioactive agent delivery
FR2924615B1 (fr)	2007-12-07	2010-01-22	Vivacy Lab	Hydrogel cohesif biodegradable.
EP2222715B1 (fr) *	2007-12-19	2019-07-24	Evonik Degussa GmbH	Acide hyaluronique réticulé en émulsion
RU2366666C1 (ru) *	2007-12-20	2009-09-10	Институт синтетических полимерных материалов (ИСПМ) им. Н.С. Ениколопова РАН	Способ получения сшитых солей гиалуроновой кислоты в водной среде
US7763268B2 (en) *	2008-01-18	2010-07-27	The Research Foundation Of State University Of New York	Load bearing hydrogel implants
RU2386640C2 (ru) *	2008-06-25	2010-04-20	Институт синтетических полимерных материалов (ИСПМ) им. Н.С. Ениколопова РАН	Способ получения модифицированной рибофлавином сшитой соли гиалуроновой кислоты
RU2386641C2 (ru) *	2008-07-09	2010-04-20	Институт синтетических полимерных материалов (ИСПМ) им. Н.С. Ениколопова РАН	Способ получения модифицированной ретинолом сшитой соли гиалуроновой кислоты
RU2387670C1 (ru) *	2008-07-30	2010-04-27	Институт синтетических полимерных материалов (ИСПМ) им. Н.С. Ениколопова РАН	Способ получения модифицированной фолиевой кислотой сшитой соли гиалуроновой кислоты
RU2387671C1 (ru) *	2008-07-30	2010-04-27	Институт синтетических полимерных материалов (ИСПМ) им. Н.С. Ениколопова РАН	Способ получения модифицированной витаминами сшитой соли гиалуроновой кислоты
US8450475B2 (en) *	2008-08-04	2013-05-28	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
JP5722217B2 (ja)	2008-09-02	2015-05-20	アラーガン・ホールディングス・フランス・ソシエテ・パール・アクシオン・サンプリフィエＡｌｌｅｒｇａｎＨｏｌｄｉｎｇｓＦｒａｎｃｅＳ．Ａ．Ｓ．	ヒアルロン酸および／またはその誘導体の糸、その作製方法、ならびにその使用
TWI387620B (zh) *	2008-09-23	2013-03-01	Scivision Biotech Inc	交聯透明質酸之製造方法
ES2829956T3 (es)	2008-10-02	2021-06-02	Lrr & D Ltd	Apósito para heridas en capa de interfaz
WO2010042493A1 (fr) *	2008-10-06	2010-04-15	Allergan, Inc.	Bande gastrique mécanique avec coussins
US20100305397A1 (en) *	2008-10-06	2010-12-02	Allergan Medical Sarl	Hydraulic-mechanical gastric band
CN101721349B (zh)	2008-10-16	2011-07-20	常州百瑞吉生物医药有限公司	可注射原位交联水凝胶及其制备方法和用途
US20100185049A1 (en)	2008-10-22	2010-07-22	Allergan, Inc.	Dome and screw valves for remotely adjustable gastric banding systems
CZ2008705A3 (cs)	2008-11-06	2010-04-14	Cpn S. R. O.	Zpusob prípravy DTPA sítovaných derivátu kyseliny hyaluronové a jejich modifikace
US8679470B2 (en)	2008-11-28	2014-03-25	Luromed Llc	Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications
JP2010202522A (ja) *	2009-02-27	2010-09-16	Shiseido Co Ltd	耐塩性増粘剤及びそれを配合した化粧料
CA2757557C (fr) *	2009-04-02	2017-06-27	Allergan, Inc.	Hydrogels en forme de cheveu pour augmentation des tissus mous
US9371402B2 (en)	2009-04-09	2016-06-21	Scivision Biotech Inc.	Method for producing cross-linked hyaluronic acid
EP2424583A2 (fr) *	2009-05-01	2012-03-07	Allergan, Inc.	Bande gastrique laparoscopique avec agents actifs
US20110184229A1 (en) *	2009-05-01	2011-07-28	Allergan, Inc.	Laparoscopic gastric band with active agents
IT1399351B1 (it)	2009-06-16	2013-04-16	Fidia Farmaceutici	Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi
AU2010276574B2 (en)	2009-07-30	2015-08-20	Carbylan Therapeutics, Inc.	Modified hyaluronic acid polymer compositions and related methods
WO2011031400A2 (fr) *	2009-08-28	2011-03-17	Allergan, Inc.	Bande gastrique avec stimulation électrique
US20110137112A1 (en) *	2009-08-28	2011-06-09	Allergan, Inc.	Gastric band with electric stimulation
US8273725B2 (en)	2009-09-10	2012-09-25	Genzyme Corporation	Stable hyaluronan/steroid formulation
US8247390B2 (en) *	2009-09-28	2012-08-21	Luromed Llc	Modified hydrophilic polymers containing hydrophobic groups
EP2503888A4 (fr) *	2009-11-23	2015-07-29	Cerulean Pharma Inc	Polymères à base de cyclodextrine pour une administration thérapeutique
US9114188B2 (en)	2010-01-13	2015-08-25	Allergan, Industrie, S.A.S.	Stable hydrogel compositions including additives
US20110171311A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie, Sas	Stable hydrogel compositions including additives
US20110172180A1 (en)	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
US20110171286A1 (en) *	2010-01-13	2011-07-14	Allergan, Inc.	Hyaluronic acid compositions for dermatological use
US8758221B2 (en) *	2010-02-24	2014-06-24	Apollo Endosurgery, Inc.	Source reservoir with potential energy for remotely adjustable gastric banding system
US8840541B2 (en) *	2010-02-25	2014-09-23	Apollo Endosurgery, Inc.	Pressure sensing gastric banding system
CA2792729C (fr) *	2010-03-12	2016-06-28	Allergan Industrie, Sas	Composition fluide pour l'amelioration d'etats cutanes
HUE030138T2 (en)	2010-03-22	2017-04-28	Allergan Inc	Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US9044298B2 (en)	2010-04-29	2015-06-02	Apollo Endosurgery, Inc.	Self-adjusting gastric band
US20110270024A1 (en)	2010-04-29	2011-11-03	Allergan, Inc.	Self-adjusting gastric band having various compliant components
US9028394B2 (en)	2010-04-29	2015-05-12	Apollo Endosurgery, Inc.	Self-adjusting mechanical gastric band
US20110270025A1 (en)	2010-04-30	2011-11-03	Allergan, Inc.	Remotely powered remotely adjustable gastric band system
US8517915B2 (en)	2010-06-10	2013-08-27	Allergan, Inc.	Remotely adjustable gastric banding system
JP2013530785A (ja)	2010-07-12	2013-08-01	シン・プーン・ファーマシューティカル・カンパニー・リミテッド	組織増大用充填組成物
US8697057B2 (en)	2010-08-19	2014-04-15	Allergan, Inc.	Compositions and soft tissue replacement methods
US8889123B2 (en)	2010-08-19	2014-11-18	Allergan, Inc.	Compositions and soft tissue replacement methods
US9005605B2 (en)	2010-08-19	2015-04-14	Allergan, Inc.	Compositions and soft tissue replacement methods
US8883139B2 (en)	2010-08-19	2014-11-11	Allergan Inc.	Compositions and soft tissue replacement methods
US20120059216A1 (en)	2010-09-07	2012-03-08	Allergan, Inc.	Remotely adjustable gastric banding system
US8961393B2 (en)	2010-11-15	2015-02-24	Apollo Endosurgery, Inc.	Gastric band devices and drive systems
CZ303548B6 (cs)	2011-01-05	2012-11-28	Contipro Pharma A.S.	Zdravotní prípravek tvorící jód, zpusob jeho prípravy a bandáž, která jej obsahuje
WO2012140650A2 (fr)	2011-04-12	2012-10-18	Hepacore Ltd.	Conjugués de carboxy polysaccharides avec des facteurs de croissance des fibroblastes et variants de ceux-ci
US9381269B2 (en)	2011-04-13	2016-07-05	Avent, Inc.	Biosorbable wound treatment device, process for making, and method of using the same
US9492383B2 (en)	2011-04-20	2016-11-15	Carbylan Therapeutics, Inc.	Rapid in-situ gel forming compositions prepared via reaction of vinyl sulfone derivatized hyaluronic acid with thiol derivatized polyethylene glycol at alkaline pH
ITTO20110428A1 (it)	2011-05-13	2012-11-14	Rottapharm Spa	Esteri dell'acido ialuronico, loro preparazione ed uso in dermatologia
AU2012262047A1 (en)	2011-06-03	2014-01-16	Allergan, Inc.	Dermal filler compositions including antioxidants
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
CN103687622A (zh)	2011-06-16	2014-03-26	香港科技大学	含有多个乙烯砜的分子
WO2013010045A1 (fr)	2011-07-12	2013-01-17	Biotime Inc.	Nouveaux procédés et formulations pour thérapie cellulaire orthopédique
SI2742070T1 (sl)	2011-08-10	2021-11-30	Glycores 2000 Srl	Proti razgrajevanju odporen, zamreženi hialuronat z nizko molekularno maso
US9662422B2 (en)	2011-09-06	2017-05-30	Allergan, Inc.	Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en)	2011-09-06	2013-09-19	Allergan, Inc.	Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US20140256695A1 (en) *	2011-11-11	2014-09-11	Phi Nguyen	Injectable filler
FR2983483B1 (fr)	2011-12-02	2014-11-14	Vivacy Lab	Procede de substitution et reticulation simultanees d'un polysaccharide via ses fonctions hydroxyles
US8876694B2 (en)	2011-12-07	2014-11-04	Apollo Endosurgery, Inc.	Tube connector with a guiding tip
US8961394B2 (en)	2011-12-20	2015-02-24	Apollo Endosurgery, Inc.	Self-sealing fluid joint for use with a gastric band
JP6316537B2 (ja) *	2011-12-20	2018-04-25	三洋化成工業株式会社	分岐ヒアルロン酸及びその製造方法
WO2013109959A1 (fr) *	2012-01-18	2013-07-25	University Of Kansas	Particules d'acide hyaluronique et leur utilisation dans des applications biomédicales
AU2013237894B2 (en)	2012-03-30	2018-06-21	The Board Of Regents Of The University Of Oklahoma	High molecular weight heparosan polymers and methods of production and use thereof
CZ2012282A3 (cs)	2012-04-25	2013-11-06	Contipro Biotech S.R.O.	Zesítovaný derivát hyaluronanu, zpusob jeho prípravy, hydrogel a mikrovlákna na jeho bázi
ITPD20120173A1 (it)	2012-05-31	2013-12-01	Fidia Farmaceutici	"nuovo sistema di rilascio di proteine idrofobiche"
US20140094432A1 (en)	2012-10-02	2014-04-03	Cerulean Pharma Inc.	Methods and systems for polymer precipitation and generation of particles
US9744260B2 (en) *	2013-04-12	2017-08-29	Phi Nguyen	Timing controlled in-situ cross-linking of halyuronic acid during injection
RU2640865C2 (ru) *	2013-06-28	2018-01-12	Гальдерма С.А.	Способ производства формованного продукта из поперечно-сшитой гиалуроновой кислоты
CN103333349A (zh) *	2013-06-28	2013-10-02	陕西巨子生物技术有限公司	一种注射用透明质酸-胶原蛋白复合水凝胶及其制备方法
EP2832378A2 (fr)	2013-08-01	2015-02-04	Ivis Technologies S R L	Adhésif biopolymère approprié pour être utilisé comme remplacement temporaire de l'épithélium
TWI482634B (zh) *	2013-10-24	2015-05-01	Ind Tech Res Inst	生醫組合物
KR101459070B1 (ko)	2013-12-09	2014-11-17	(주) 뉴메딕	지속성을 갖는 히알루론산 겔 조성물
AR099900A1 (es)	2014-04-01	2016-08-24	Merz Pharma Gmbh & Co Kgaa	Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso
JP2017527422A (ja)	2014-08-15	2017-09-21	ザ・ジョンズ・ホプキンス・ユニバーシティー	組織修復のための複合材料
WO2016051219A1 (fr)	2014-09-30	2016-04-07	Allergan Industrie, Sas	Compositions d'hydrogel stables pourvues d'additifs
KR101694121B1 (ko)	2014-10-28	2017-01-10	(주)헵틸와이	이중 가교구조의 생체친화형 다공성 시트 및 그 제조방법
US10077420B2 (en)	2014-12-02	2018-09-18	Histogenics Corporation	Cell and tissue culture container
KR101521058B1 (ko)	2014-12-08	2015-05-15	이노팜 주식회사	생체적합성 조성물 및 이의 제조방법
CN104530460A (zh) *	2014-12-19	2015-04-22	大连理工大学	糖基化高分子材料及其制备方法
WO2016128783A1 (fr)	2015-02-09	2016-08-18	Allergan Industrie Sas	Compositions et méthodes pour améliorer l'apparence de la peau
EP3653232A1 (fr)	2015-02-13	2020-05-20	Allergan Industrie, SAS	Implants pour sculpter, augmenter ou corriger des caractéristiques faciales telles que le menton
US9855317B2 (en)	2015-04-27	2018-01-02	Reflex Medical, Inc.	Systems and methods for sympathetic cardiopulmonary neuromodulation
EP3316921B1 (fr) *	2015-06-30	2021-05-05	Merz Pharma GmbH & Co. KGaA	Procédé de production d'acide hyaluronique réticulé
KR101818705B1 (ko)	2015-07-20	2018-01-16	포항공과대학교 산학협력단	약물이 충전된 히알루론산 가교물 하이드로겔 및 이의 이용
KR20170025778A (ko)	2015-08-31	2017-03-08	대화제약 주식회사	항산화제를 포함하는 생체 적합성 고분자 히알루론산 유도체 및 그 히알루론산의 가교결합물
CA3005438A1 (fr) *	2015-11-18	2017-05-26	Lifecell Corporation	Maille revetue d'hydrogel
US11246879B2 (en)	2016-02-09	2022-02-15	Tulai Therapeutics, Inc.	Methods, agents, and devices for local neuromodulation of autonomic nerves
KR101866310B1 (ko)	2016-05-31	2018-06-11	주식회사 글랜젠	생체 내 지속성 및 항산화 작용이 향상된 진피 충전재 조성물 및 이의 제조방법
CA3031761A1 (fr)	2016-06-29	2018-01-04	Tulavi Therapeutics, Inc.	Traitement de la septicemie et des etats inflammatoires associes par neuromodulation locale du systeme nerveux autonome
MA46426A (fr)	2016-09-16	2019-07-24	Glycologix Llc	Biomatériaux à base de glycosaminoglycanes sulfatés utilisés en tant que mimétiques de protéoglycanes
CZ2016826A3 (cs)	2016-12-22	2018-07-04	Contipro A.S.	Léčivý prostředek s nosičem na bázi hyaluronanu a/nebo jeho derivátů, způsob výroby a použití
CA3052135C (fr)	2017-02-02	2022-01-11	Amtixbio Co., Ltd.	Hydrogel utilisant en tant que substrat un derive d'acide hyaluronique modifie par un groupe gallol, et utilisation associee
US20190240335A1 (en)	2018-02-07	2019-08-08	Promedon S.A.	Biocompatible Hydrogel Compositions
US20210260213A1 (en) *	2018-03-29	2021-08-26	Ramesh S. Ayyala	Methods and compositions for delivery of a therapeutic agent
EP3790602A1 (fr)	2018-05-09	2021-03-17	The Johns Hopkins University	Composites nanofibres-hydrogel pour l'administration de cellules et de tissus
KR20210034544A (ko)	2018-05-09	2021-03-30	더 존스 홉킨스 유니버시티	향상된 연조직 대체 및 재생을 위한 나노섬유-하이드로겔 복합재료
EP3806917B1 (fr)	2018-06-15	2025-12-10	Croma-Pharma GmbH	Composition d'hydrogel comprenant un polymère réticulé
JP7374133B2 (ja) *	2018-06-15	2023-11-06	クロマ－ファーマゲゼルシャフトエム．ベー．ハー．	安定化されたヒアルロン酸
US20210315587A1 (en)	2018-07-02	2021-10-14	Tulavi Therapeutics, Inc.	Methods and devices for in situ formed nerve cap with rapid release
AU2019299519B2 (en)	2018-07-02	2025-03-06	Incept Llc	Methods and devices for in situ formed nerve cap
CN112423798B (zh)	2018-07-06	2022-07-19	株式会社Lg化学	具有高粘弹性和高内聚性的透明质酸填充剂
BR112021000361B1 (pt)	2018-07-10	2023-12-05	Lg Chem, Ltd	Enchimentos de hidrogel de ácido hialurônico com alta capacidade de levantamento e baixa força de injeção, método para preparação dos mesmos, seringa pré enchida, biomaterial para aumentar o tecido mole e usos dos ditos enchimentos para aumentar o tecido mole e melhorar as rugas
CA3122116C (fr)	2018-12-20	2023-07-18	Lg Chem, Ltd.	Charge presentant d'excellentes proprietes de charge comprenant un hydrogel d'acide hyaluronique
BR112021012059A2 (pt)	2018-12-21	2021-10-19	Lg Chem, Ltd.	Preenchedor compreendendo ácido hialurônico hidrogel com excelentes propriedades de preenchimento
KR102162724B1 (ko)	2020-03-24	2020-10-07	바이오플러스 주식회사	가교 히알루론산 겔 및 이의 제조 방법
JP7385876B2 (ja)	2020-03-31	2023-11-24	株式会社クレハ	生体吸収性医療材料
CN115768496A (zh) *	2020-05-14	2023-03-07	阿勒根制药国际有限公司	包括与透明质酸交联的原弹性蛋白的组合物及其使用方法
KR102366394B1 (ko) *	2021-01-05	2022-02-23	조광용	고팽윤성 히알루론산 비드 겔
KR20220106283A (ko)	2021-01-22	2022-07-29	(주)앰틱스바이오	자가 가교형 히알루론산 유도체 기반 창상피복재
KR102598899B1 (ko) *	2021-05-13	2023-11-07	주식회사 바이오스탠다드	히알루론산 기반 기능성 하이드로겔 복합체 및 이의 제조방법
WO2023010115A1 (fr) *	2021-07-30	2023-02-02	Regents Of The University Of Minnesota	Biomatériaux pour l'embolisation et l'administration de médicament
CN117915933A (zh)	2021-09-01	2024-04-19	上海其胜生物制剂有限公司	使用含有软骨细胞或干细胞的可注射可原位聚合胶原组合物进行软骨再生
US20240269349A1 (en)	2021-09-09	2024-08-15	Sunbio Inc.	Sol-gel conversion over time of 6-arm peg hydrogel
US12304974B2 (en)	2021-12-28	2025-05-20	Shanghai Qisheng Biological Preparation Co., Ltd.	Hyaluronic acid-collagen copolymer compositions and medical applications thereof
KR20260009267A (ko) *	2023-02-15	2026-01-19	라이프스프라웃, 인크.	변형된 가교된 중합체
WO2025091137A1 (fr)	2023-11-02	2025-05-08	Volumina Medical Sa	Compositions de dispositif implantable comprenant des liaisons ester

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1047380B (de) *	1954-08-18	1958-12-24	American Home Prod	Verfahren zur Herstellung einer hyaluronidasefreien, teilweise depolymerisierte Hyaluronsaeure enthaltenden waessrigen Traegerloesung fuer Arzneimittel
DE1043589B (de) *	1956-01-02	1958-11-13	Kisaku Ibe	Haut- und Haarpflegemittel und Verfahren zu ihrer Herstellung
US3357784A (en) *	1964-09-30	1967-12-12	Kendall & Co	Exposure to intense ultraviolet light to improve characteristics of cellulosic fabrics in divinyl sulfone and glyoxal cross-linking processes
SE361320B (fr) *	1972-03-14	1973-10-29	Exploaterings Ab Tbf
US4152170A (en)	1975-06-18	1979-05-01	Sumitomo Chemical Company, Ltd.	Cross-linked pullulan
GB1515963A (en) *	1975-07-15	1978-06-28	Massachusetts Inst Technology	Crosslinked collagen-mucopolysaccharide composite materials
US4141973A (en) *	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
US4303676A (en) *	1980-03-21	1981-12-01	Balazs Endre A	Hyaluronate based compositions and cosmetic formulations containing same
JPS59162779A (ja) *	1983-03-04	1984-09-13	Toshiba Corp	周波数変換装置の制御方法
US4448718A (en) *	1983-09-13	1984-05-15	Massachusetts Institute Of Technology	Method for the preparation of collagen-glycosaminoglycan composite materials
US4487865A (en) *	1983-12-15	1984-12-11	Biomatrix, Inc.	Polymeric articles modified with hyaluronate
CA1238043A (fr) *	1983-12-15	1988-06-14	Endre A. Balazs	Preparations d'acide hyaluronique insolubles dans l'eau et procede de production
US4500676A (en) *	1983-12-15	1985-02-19	Biomatrix, Inc.	Hyaluronate modified polymeric articles
US4713448A (en) *	1985-03-12	1987-12-15	Biomatrix, Inc.	Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues

1984
- 1984-12-06 US US06/678,895 patent/US4582865A/en not_active Expired - Lifetime
1985
- 1985-05-08 CA CA000481055A patent/CA1230186A/fr not_active Expired
- 1985-05-13 GB GB8512072A patent/GB2168067B/en not_active Expired
- 1985-05-28 AU AU43045/85A patent/AU569157B2/en not_active Expired
- 1985-05-28 FR FR8507941A patent/FR2574414B1/fr not_active Expired
- 1985-06-04 DE DE3546811A patent/DE3546811C2/de not_active Expired - Lifetime
- 1985-06-04 DE DE19853520008 patent/DE3520008A1/de active Granted
- 1985-07-04 JP JP60147612A patent/JPS61138601A/ja active Granted
- 1985-07-15 SE SE8503486A patent/SE460792B/sv not_active IP Right Cessation
- 1985-09-09 IT IT22089/85A patent/IT1187737B/it active
1986
- 1986-07-31 GB GB8618719A patent/GB2181147B/en not_active Expired
- 1986-07-31 GB GB8618720A patent/GB2181148B/en not_active Expired
1987
- 1987-04-28 AU AU72173/87A patent/AU572419B2/en not_active Expired
1988
- 1988-07-26 GB GB8817772A patent/GB2205848B/en not_active Expired
1989
- 1989-05-10 SE SE8901672A patent/SE501828C2/sv not_active IP Right Cessation
- 1989-09-06 JP JP1232667A patent/JPH0637575B2/ja not_active Expired - Lifetime

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5633001A (en) *	1993-03-19	1997-05-27	Medinvent	Composition and a method for tissue augmentation
US5827937A (en) *	1995-07-17	1998-10-27	Q Med Ab	Polysaccharide gel composition

Also Published As

Publication number	Publication date
JPS61138601A (ja)	1986-06-26
GB2181147B (en)	1989-06-07
SE8503486D0 (sv)	1985-07-15
FR2574414B1 (fr)	1987-07-03
IT1187737B (it)	1987-12-23
SE8901672D0 (sv)	1989-05-10
GB2168067A (en)	1986-06-11
GB2181147A (en)	1987-04-15
SE8503486L (sv)	1986-06-07
GB2205848B (en)	1989-05-24
JPH0637575B2 (ja)	1994-05-18
AU569157B2 (en)	1988-01-21
GB2181148B (en)	1989-06-07
DE3520008C2 (fr)	1991-10-10
GB8512072D0 (en)	1985-06-19
AU572419B2 (en)	1988-05-05
AU7217387A (en)	1987-08-27
AU4304585A (en)	1986-06-12
CA1230186A (fr)	1987-12-08
JPH02138346A (ja)	1990-05-28
FR2574414A1 (fr)	1986-06-13
IT8522089A0 (it)	1985-09-09
GB2181148A (en)	1987-04-15
GB8817772D0 (en)	1988-09-01
JPH0430961B2 (fr)	1992-05-25
GB2205848A (en)	1988-12-21
GB2168067B (en)	1989-06-07
GB8618719D0 (en)	1986-09-10
US4582865A (en)	1986-04-15
SE8901672L (sv)	1989-05-10
DE3520008A1 (de)	1986-06-19
GB8618720D0 (en)	1986-09-10
SE501828C2 (sv)	1995-05-22
DE3546811C2 (fr)	1993-09-02

Legal Events

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 8503486-6

Format of ref document f/p: F

2005-08-30

NUG

Patent has lapsed

Publication	Publication Date	Title
US4582865A (en)	1986-04-15	Cross-linked gels of hyaluronic acid and products containing such gels
US4636524A (en)	1987-01-13	Cross-linked gels of hyaluronic acid and products containing such gels
US4605691A (en)	1986-08-12	Cross-linked gels of hyaluronic acid and products containing such gels
AU773628B2 (en)	2004-05-27	Process for cross-linking hyaluronic acid to polymers
Preston et al.	1965	The composition and physicochemical properties of hyaluronic acids prepared from ox synovial fluid and from a case of mesothelioma
AU773518B2 (en)	2004-05-27	Process for the production of multiple cross-linked hyaluronic acid derivatives
Amiji	1998	Platelet adhesion and activation on an amphoteric chitosan derivative bearing sulfonate groups
JPS614760A (ja)	1986-01-10	ヒアルロン酸塩−ポリ（エチレンオキサイド）組成物及びその化粧用製剤
JPH0353321B2 (fr)	1991-08-14
US7521434B2 (en)	2009-04-21	Cross-linked gels of hyaluronic acid with hydrophobic polymers and processes for making them
KR20010034137A (ko)	2001-04-25	설페이트화 사카라이드
CN112190502B (zh)	2023-05-16	一种透明质酸季铵盐复合物
Yermak et al.	2021	Carrageenan gel beads for echinochrome inclusion: Influence of structural features of carrageenan
Eteshola et al.	1996	Dilute solution viscosity of red microalga exopolysaccharide
WO1998030595A1 (fr)	1998-07-16	Acide hyaluronique oligosulfate
ES2370093T3 (es)	2011-12-12	Procedimiento de preparación de derivados (poli(óxido de etileno) poli(óxido de propileno)) termosensibles, útiles para funcionalizar el quitosano.
Ninomiya et al.	1969	Bacterial polysaccharide from Bacillus polymyxa No. 271
JPS60233101A (ja)	1985-11-19	架橋ヒアルロン酸
JP3047058B2 (ja)	2000-05-29	硫酸化多糖含有油中水型乳化組成物
CN113388168A (zh)	2021-09-14	一种透明质酸纳米微球复合物、制备方法及应用
KR20230116318A (ko)	2023-08-04	마이크로파이버 제조 방법 및 화장료 조성물
CN115768397B (zh)	2025-02-25	包含短链脂肪酸盐的胶凝组合物
Schuerch	1985	Biomedical applications of polysaccharides
JPH0586234B2 (fr)	1993-12-10
EP0280807A1 (fr)	1988-09-07	Mélanges d'hyalaronate ou d'hylan avec du polyéthylène oxide

SE460792B - Metod foer framstaellning av tvaerbunden hyaluronsyragel, tvaerbunden gel framstaelld enligt denna metod, blandning av tvaerbunden hyaluronsyra gel med annan hydrofil polymer samt kompositioner som innehaaller denna gel - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (1)

Publications (3)

Family

ID=24724742

Family Applications (2)

Family Applications After (1)

Country Status (9)

Cited By (2)

Families Citing this family (296)

Family Cites Families (14)

Cited By (2)

Also Published As

Similar Documents

Legal Events